AntiplateletsBleeding and the associated complications: 18 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1660卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33014-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：49 / 49

相关论文

共 50 条

[1] Anticoagulants/antiplateletsBleeding: 14 case reports
[J]. Reactions Weekly, 2020, 1833 (1) : 43 - 43
[2] Anticoagulants/antiplateletsBleeding: 8 case reports
[J]. Reactions Weekly, 2021, 1869 (1) : 33 - 33
[3] Anticoagulants/antiplateletsBleeding: 192 case reports
[J]. Reactions Weekly, 2021, 1860 (1) : 44 - 44
[4] Anticoagulants/antiplateletsBleeding events: 6 case reports
[J]. Reactions Weekly, 2020, 1830 (1) : 39 - 39
[5] ImmunosuppressantsCandidaemia and associated complications: 6 case reports
[J]. Reactions Weekly, 2019, 1764 (1) : 170 - 170
[6] Anticoagulants/antiplateletsBleeding events and off-label use: 26 case reports
[J]. Reactions Weekly, 2020, 1802 (1) : 42 - 42
[7] AntineoplasticsPortal hypertension and associated complications: 3 case reports
[J]. Reactions Weekly, 2019, 1749 (1) : 52 - 53
[8] Antithymocyte globulinLymphopenia and associated complications: 12 case reports
[J]. Reactions Weekly, 2018, 1683 (1) : 89 - 89
[9] PyridoxineRebound effect and associated complications: 2 case reports
[J]. Reactions Weekly, 2019, 1778 (1) : 402 - 402
[10] TioguanineHepatoportal toxicity and associated complications: 11 case reports
[J]. Reactions Weekly, 2017, 1670 (1) : 268 - 268

← 1 2 3 4 5 →